Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of a Risk Prediction Model for Immune-Targeted Therapy-Related Diarrhea in Patients With Hepatocellular Carcinoma Based on TCM Constitutional Types: A Prospective Cohort Study

NCT07741903 is registered in ClinicalTrials.gov with Affiliated Hospital of Chengde Medical University as lead sponsor.

NCT NCT07741903
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07741903 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of a Risk Prediction Model for Immune-Targeted Therapy-Related Diarrhea in Patients With Hepatocellular Carcinoma Based on TCM Constitutional Types: A Prospective Cohort Study
Lead sponsor
Affiliated Hospital of Chengde Medical University
Phase
Observational
Overall status
Not yet recruiting
Start date
January 31, 2027
Completion date
January 31, 2030
Enrollment
500 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

liver cancer